| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.50▼ | 4.56▼ | 4.53▼ | 4.45▲ | 4.77▼ |
| MA10 | 4.51▼ | 4.53▼ | 4.55▼ | 4.64▼ | 4.61▼ |
| MA20 | 4.54▼ | 4.57▼ | 4.53▼ | 4.80▼ | 4.07▲ |
| MA50 | 4.54▼ | 4.47▲ | 4.53▼ | 4.59▼ | 2.33▲ |
| MA100 | 4.57▼ | 4.59▼ | 4.83▼ | 3.89▲ | 1.76▲ |
| MA200 | 4.48▲ | 4.85▼ | 4.61▼ | 2.53▲ | 5.89▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.006▼ | -0.010▼ | -0.001▼ | -0.070▼ | -0.037▼ |
| RSI | 38.938▼ | 47.033▼ | 47.691▼ | 47.220▼ | 58.858▲ |
| STOCH | 8.333▼ | 53.510 | 40.575 | 20.248 | 62.129 |
| WILL %R | -100.000▼ | -66.667 | -67.857 | -71.127 | -38.287 |
| CCI | -68.617 | -36.360 | -71.402 | -59.940 | 6.372 |
|
Monday, June 15, 2026 08:55 AM
Track conference calls, annual meetings, summits, analyst days and other corporate events scheduled for AN2 Therapeutics Inc. Use the full market events calendar to scan activity across all tickers.
|
|
Monday, January 12, 2026 07:16 AM
(RTTNews) - AN2 Therapeutics Inc. (ANTX) announced that the U.S. FDA has cleared its investigator-initiated trial evaluating Epetraborole in 90 patients with Mycobacterium abscessus lung disease, ...
|
|
Monday, April 14, 2025 02:56 PM
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/07/26 | 4.56 | 4.68 | 4.41 | 4.50 | 576,207 |
| 09/07/26 | 4.44 | 4.69 | 4.44 | 4.63 | 99,070 |
| 08/07/26 | 4.17 | 4.46 | 4.09 | 4.41 | 538,318 |
| 07/07/26 | 4.42 | 4.56 | 4.1801 | 4.30 | 187,880 |
| 06/07/26 | 4.39 | 4.50 | 4.30 | 4.41 | 130,097 |
| 02/07/26 | 4.71 | 4.78 | 4.41 | 4.42 | 143,766 |
| 01/07/26 | 4.82 | 5.01 | 4.59 | 4.70 | 113,232 |
| 30/06/26 | 5.01 | 5.125 | 4.80 | 4.84 | 152,426 |
| 29/06/26 | 5.23 | 5.26 | 4.69 | 5.03 | 323,978 |
| 26/06/26 | 5.16 | 5.37 | 4.94 | 5.20 | 3,646,247 |
|
|
||||
|
|
||||
|
|